Blackstone Inc
AEON.WS

Blackstone Inc’s AEON Biopharma Inc AEON.WS Stock Holding History

Blackstone Inc’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-166,666
Closed -$85K – 343
2021
Q4 		$85K Hold
166,666
– – ﹤0.01% 465
2021
Q3 		$97K Hold
166,666
– – ﹤0.01% 538
2021
Q2 		$167K Buy
+166,666
New +$126K ﹤0.01% 512

Other funds holding AEON.WS

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Blackstone Inc's AEON.WS Position: Q1 2022 in Review

Blackstone Inc sold out of AEON Biopharma Inc (AEON.WS) in Q1 2022, closing a stake of 166,666 shares — an estimated $85K sold.

Blackstone Inc first reported a position in AEON.WS in Q2 2021 and held it in 3 quarters. The position peaked at $167K in Q2 2021. 50 funds tracked by Wall St. Rank hold AEON.WS as of Q1 2022.

  • Blackstone Inc reported no remaining AEON Biopharma Inc position as of Q1 2022 after selling out during the quarter.
  • Blackstone Inc sold 166,666 AEON Biopharma Inc shares in Q1 2022, an estimated $85K.
  • Blackstone Inc first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 3 quarters.
  • Blackstone Inc's AEON Biopharma Inc position peaked at $167K in Q2 2021.
  • 50 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q1 2022.

Based on Blackstone Inc's 13F filing for Q1 2022, filed 16 May 2022.